home of the INTERNATIONAL ATHEROSCLEROSIS SOCIETY
  ABOUT IAS  | IAS LEADERSHIP  | MEMBER SOCIETIES  | MEMBERSHIP contact us  | home   

IAS Prevention Guideline plus relevant cardiovascular guidelines from other organizations
Previous and future meetings sponsored by the IAS, the IAS member societies, or relevant affiliated organizations
Current and prior publications that have been sponsored by the IAS, including previous IAS newsletters
Distinguished Fellows of the IAS
Slides available through the IAS, Lorenzini Foundation, and other sites.
IAS monthly newsletter sent by email to all IAS members
Monthly summary of the key literature	in the atherosclerosis field provided each month to all IAS members.
The IAS offers fellowships to young investigators to study in major laboratories
Important websites related to atherosclerosis and related diseases
Computer based algorithms for 10-year risk assessment for cardiovascular disease.
Organizations affiliated with the IAS.

 

apo / lipoproteins



CLICK HERE TO VIEW THE LIST OF ALL COMMENTARIES PER SINGLE AUTHOR

CLICK HERE TO VIEW THE LIST OF LATEST COMMENTARIES

 

The list is in chronological order of the dates Commentaries were received by IAS

MONTH/YEAR
AUTHORS

TITLE

JULY
2015
 
A.N. Orekhov,
I.A. Sobenin,
Y.V. Bobryshev
FEBRUARY
2015
 
M. Das,
O. Gursky
JANUARY
2013
 
M.J. Thomas,
M.G. Sorci-Thomas
APRIL
2012
 
C.L. Teoh,
M.D.W. Griffin,
G.J. Howlett
AUGUST
2011
 
R. Asmis
JULY
2011
 
A. Pirillo,
A. L. Catapano
JUNE
2011
 
B. De Geest, S. Gordts, E. Van Craeyveld, F. Jacobs
APRIL
2010
 
K-H. Cho
MARCH
2010
 
R.W. Mahley
JUNE2009 
B.E. Bihain,
F.T. Yen
MAY
2009
 
G.S. Getz,
P.A. VanderLaan,
C.A. Reardon
DECEMBER
2008
 
B. Garner
 
M.R. Langlois
JULY
2008
 
S. Lamon-Fava
MAY
2008
 
A. Panayiotou,
M. Griffin,
N. Georgiou,
D. Bond,
T. Tyllis,
C. Chakouri,
C. Fessas,
A. Nicolaides
MARCH
2008
 
K. Tosheska,
D. Labudovic,
S. Alabakovska,
M. Spiroski,
B. Todorova
DECEMBER
2007
 
K-A. Rye
 
A. Onat,
G. Hergenc
SEPTEMBER
2007
 
C. Hu,
A. Dandapat,
J.L. Mehta
 
G.N. Fredrikson,
J. Nilsson
JUNE
2007
 
E. Matsuura,
K. Inoue,
L.R. Lopez
JANUARY
2007
J. Sierra-Johnson,
V.K. Somers,
F. Lopez-Jimenez

 
M. Rizzo ,
K. Berneis

AUGUST
2006
S. Mora
JULY
2006
O. Méndez,
N. Duhal,
B. Lacroix,
J.-P. Bonte,
J.-C. Fruchart,
G. Luc
  J. Heeren
The Recycling of Apolipoprotein E: Potential Role for the Development of Dyslipidemias and Atherosclerosis
JUNE
2006
C . Gazzaruso
Lipoprotein(a), Apolipoprotein(a) Polymorphism and Coronary Artery Disease Severity in Type 2 Diabetes Mellitus
MAY
2006
A. D. Mooradian
MARCH
2006
E.J. Schaefer,
B.F. Asztalos

 
J. M. Arbonés-Mainar,
M. A. Navarro,
C. Arnal,
H.M. Roche,
J. Osada
FEBRUARY
2006
V. Charlton-Menys,
P. N. Durrington
JANUARY
2006
S. Yokoyama
  S. Olofsson,
J. Borén
DECEMBER
2005
N. Tamasawa
OCTOBER 2005
N. N. Singh
D. P. Ramji
JULY
2005
Maria M. Stollenwerk,
Mikko P.S. Ares
JUNE
2005
F.J. Tinahones Madueño,
L.G. Sánchez

MAY
2005
A. Simon,
J. Levenson
 
G. Paragh
APRIL
2005
R.L. Raffai
MARCH
2005
A. J. Hooper,
P. Hugh R. Barrett,
F. M. van Bockxmeer,
J. R. Burnett
Impact Of APOB Mutations On Lipoprotein Metabolism
 
L. Schreier
FEBRUARY 2005 M. Mackness,
B. Mackness
 
A. Saitta
M.A. Sardo
A. Bonaiuto
A. Bitto
M. Castaldo
M. Bonaiuto
C. Saitta
 
M.R. Hayden
JANUARY 2005
A.D. Tselepis
DECEMBER 2004
J. Ducobu,
K.Z. Boudjeltia,
N. Moguilevsky,
M. Vanhaeverbeek
NOVEMBER 2004
C.Y. Chou,
M.S. Shiao,
G.G. Chang
 
K.G. Jackson,
C.M. Williams
JUNE
2004
M.L. Koschinsky
NOVEMBER 2003

J. Burges,
D.L. Sparks

OCTOBER 2003

S.S. Deeb

VARIATION IN HEPATIC LIPASE ACTIVITY AND ITS IMPACT ON THE LIPOPROTEIN PROFILE AND ATHEROSCLEROSIS

JULY
2003

S. Miura
K. Saku

MOLECULAR MECHANISMS OF HIGH-DENSITY LIPOPROTEIN-INDUCED ANGIOGENESIS

JUNE
2003

M. Husmann

NOT A MILDLY MODIFIED MODEL OF MODIFICATION, THE “MAINZ HYPOTHESIS” HOLDS THAT LDL MAY BECOME A THREAT IN THE ABSENCE OF OXIDATION AND INFECTION

 

F. M. Sacks

APOLIPOPROTEIN CIII AND E IN APOB LIPOPROTEINS, AS PREDICTORS OF CORONARY DISEASE

MAY
2003

J. Ordóñez-Llanos
S. Benítez,
J. Sánchez-Quesada

ELECTRONEGATIVE LDL. A PLASMA-CIRCULATING MODIFIED LDL WITH INFLAMMATORY PROPERTIES0

 

J. L. Metha

OXIDATIVE STRESS, ATHEROSCLEROSIS, OXIDIZED-LDL, AND CD40/CD40L SIGNALING

 

G.R. Thompson

EXTRA-CORPOREAL REMOVAL OF LDL

APRIL
2003

L. Badimon

THE ROLE OF HEPARAN SULFATE PROTEOGLYCANS AS TRUE AGGREGATED LDL RECEPTORS DEPENDS ON THE CELLULAR TYPE

MARCH
2003

D. Sviridov,
P. Nestel,
W. Domain

FUNCTIONALITY OF REVERSE CHOLESTEROL TRANSPORT

FEBRUARY 2003

H. Snieder

GENETIC AND ENVIRONMENTAL INFLUENCES ON LIPIDS, LIPOPROTEINS AND APOLIPOPROTEINS: THE ROLE OF TWIN STUDIES

JANUARY 2003

N. Fournier
J. Paul

DO THE HYPERTRIGLYCERIDEMIC SUBJECTS EXHIBIT REDUCED CHOLESTEROL EFFLUX CAPACITIES?

 

I. L. Ruel
e B. Lamarch

THE ASSOCIATION OF LIPOPROTEIN LIPASE GENE MUTATIONS WITH LDL PARTICLE SIZE PHENOTYPE

 

Anglés-Cano E.

DETERMINANTS OF APOLIPOPROTEIN(a) SIZE-DEPENDANT ANTIFIBRINOLYTIC CAPACITY OF LIPOPROTEIN(a)

DECEMBER 2002

J. Hulthe,
B. Fagerberg

MEASUREMENTS OF CIRCULATING OXIDIZED LDL - A MARKER OF ATHEROSCLEROSIS DEVELOPMENT IN MAN?

OCTOBER 2002

G. Luc

LIPOPROTEIN (A) AND CORONARY HEART DISEASE

 

K. A. Dugi

THE ROLE OF LIPOPROTEIN LIPASE AND HEPATIC LIPASE IN ATHEROSCLEROSIS

 

J. S. Millar

THE ROLE OF THE LDL RECEPTOR IN DETERMINING THE APOB PRODUCTION RATE

SEPTEMBER 2002

B. Vergès

APOA-IV AND POSTPRANDIAL LIPEMIA

 

S. Rashid
G. F. Lewis

THE CONTRIBUTIONS OF TRIGLYCERIDE ENRICHMENT OF HDL AND LIPOLYSIS OF HDL BY HEPATIC LIPASE IN THE PATHOPHYSIOLOGICAL LOWERING OF HDL CONCENTRATIONS IN HYPERTRIGLYCERIDEMIC STATES

AUGUST
2002

K. M. Dalessandri

LIPOPROTEIN (A) RESEARCH: PAST, PRESENT AND FUTURE

 

A. Onat

ADVERSE RISK PROFILE IN A MEDITERRANEAN POPULATION

JULY
2002

J. Kobayashi

CLINICAL SIGNIFICANCE OF MEASURING PRE-HEPARIN LIPOPROTEIN LIPASE MASS

 

R. C. LeBoeuf

PROTEOGLYCANS AND MURINE ATHEROSCLEROSIS

JUNE
2002

H. Kamido,
A. Kuksis

CORE ALDEHYDES - A NOVEL GROUP OF BIOLOGICALLY ACTIVE OXIDIZED LIPIDS

 

S. Yamashita,
Z. Zhang,
K. Hirano,
N. Sakai, and
Y. Matsuzawa

CHOLESTERYL ESTER TRANSFER PROTEIN EXPRESSED IN HUMAN ATHEROSCLEROTIC LESIONS MAY HAVE ANTIATHEROGENIC FUNCTIONS

MAY
2002

E. J. Parks

  J. Pihlajamäki,
M. Laakso
FEBRUARY 2002 G. Schonfeld
  R. S. Rosenson
  M. Aviram,
M. Rosenblat
JANUARY 2002 D. Sviridov,
P. Nestel
  P. J Talmud
  Paul Holvoet
  R. Mahley
 


back to commentaries' index